Key Takeaways
- Origin Agritech (NASDAQ: SEED) reported first-half fiscal 2026 revenue of RMB 49.2 million (US$7.1 million), a 31.9% decline from RMB 72.3 million in the same period of fiscal 2025, primarily reflecting a deliberate shift away from external seed tolling services toward new corn seed product sales.
- Net loss attributable to Origin Agritech narrowed to RMB 14.4 million (US$2.1 million) from RMB 25.6 million a year earlier, while operating loss improved 47.8% to RMB 12.9 million (US$1.9 million).
- General and administrative expenses were cut by 69.8% year-over-year to RMB 7.6 million (US$1.1 million), and gross margin held steady at 11.2%.
- The company re-entered the Northeast China corn market in October 2025, executed a gene-editing patent license with Shunfeng BioTech, and secured two crop seed production and operation licenses across Beijing and Hainan.
- In March 2026, Origin appointed Dr. Jian Zhang as an independent director and Dr. Z. James Chen returned as CFO, strengthening the executive team's biotechnology and capital markets depth.
Origin Agritech Reports H1 Fiscal 2026 Results Amid Strategic Portfolio Transition
Origin Agritech Ltd. (NASDAQ:SEED) has released its unaudited financial results for the six months ended March 31, 2026, reporting a narrower net loss and significantly reduced operating expenses as the company continues restructuring its business around new corn seed varieties and biotechnology commercialization. Revenue declined 31.9% to RMB 49.2 million (US$7.1 million), a contraction the company attributed to a deliberate phaseout of lower-value seed tolling services in favor of proprietary product sales.
Financial Results: Losses Narrow as Cost Discipline Takes Hold
Gross profit for the half-year period was RMB 5.5 million (US$0.8 million), down from RMB 8.1 million a year earlier, though gross margin remained flat at 11.2%. Total operating expenses fell 43.9% to RMB 18.4 million (US$2.7 million), led by a 69.8% reduction in general and administrative costs to RMB 7.6 million (US$1.1 million). Selling and marketing expenses rose to RMB 5.1 million (US$0.7 million) from RMB 2.6 million, reflecting investment in the company's expanded commercial push. R&D spending edged up 11.1% to RMB 5.7 million (US$0.8 million). Operating loss improved to RMB 12.9 million (US$1.9 million) from RMB 24.7 million in the prior-year period. Basic and diluted net loss per share narrowed to RMB 1.21 (US$0.17) from RMB 3.55. As of March 31, 2026, Origin held cash and cash equivalents of RMB 13.4 million (US$1.9 million), with total assets of RMB 92.6 million (US$13.4 million) and total liabilities of RMB 168.1 million (US$24.3 million).
Origin Agritech CEO Commentary on Turnaround Progress
“Our first-half results demonstrate clear progress in our strategic turnaround. We have transferred our sales structure to our new product portfolio to align with market development, significantly reducing our operating loss and cutting general and administrative expenses by nearly 70%. This financial discipline is the direct result of the accountability structures we put in place over the past year. While top-line revenue reflects our proactive restructuring of operations — phasing out older businesses while pushing new product sales — our gross margins remained stable, and our cash position is solid,” said Weibin Yan, Chief Executive Officer of Origin Agritech.
Origin Agritech's Commercial and Regulatory Milestones
During the reporting period, Origin formally launched its “Aoyun 2026” New Variety Promotion Program at its annual marketing conference in Changsha, targeting China's principal corn-producing regions with varieties including Jingke 317, Jinqiao 8, Xundan 203, and Aoyu 728. In November 2025, the company licensed the Cas-SF01 gene-editing nuclease from Shunfeng BioTech, pairing it with Origin's proprietary Hi3 induction-line delivery platform to advance stacked-trait hybrid development. The company also secured its second crop seed production and operation license — from the Beijing Municipal Bureau of Agriculture and Rural Affairs — adding to an existing license in Hainan and meaningfully expanding its direct production and commercialization footprint.
Origin re-entered the Northeast China corn corridor in October 2025, an event that drew over 200 dealer partners and generated formal regional commercial commitments. The company's national R&D platform now holds more than 200,000 corn germplasm resources and is supported by AI-assisted breeding programs spanning genomic selection, image-based phenotyping, and gene-editing pipelines.
“In the previous quarter, our new variety promotion count and sales volume increased. We are now executing the second phase of our strategic plan. With the launch of our ‘Aoyun 2026' promotion program, we are aggressively pushing our next-generation seed varieties into the market. We have expanded both our R&D product lines and our sales force, improved our R&D network, re-entered the critical Northeast corn corridor, and secured the necessary production licenses. Furthermore, the recent appointments of Dr. Jian Zhang to our Board and the return of Dr. James Chen as CFO give us an executive team with stronger technical and capital markets expertise. We are positioned to convert our rebuilt infrastructure into tangible commercial results,” said Mr. Yan.
Read the complete financial results here.
1 Comment